These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 29610637

  • 1. Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study.
    Adibe MO, Ewelum PC, Amorha KC.
    Pan Afr Med J; 2017; 28():199. PubMed ID: 29610637
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF, Akinwumi AA, Ademola OA, Oluwole BA, Ibiene EO.
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [Abstract] [Full Text] [Related]

  • 3. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
    Fasipe OJ, Akhideno PE, Nwaiwu O, Adelosoye AA.
    Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
    [Abstract] [Full Text] [Related]

  • 4. Intradialysis blood pressure changes among chronic kidney disease patients on maintenance haemodialysis in a tertiary hospital south - south Nigeria: a 2 year retrospective study.
    Okpa HO, Effa EE, Oparah SK, Chikezie JA, Bisong EM, Mbu PN, Otokpa DE.
    Pan Afr Med J; 2019; 33():91. PubMed ID: 31489069
    [Abstract] [Full Text] [Related]

  • 5. Chronic kidney disease in children as seen in a tertiary hospital in Enugu, South-East, Nigeria.
    Odetunde OI, Okafor HU, Uwaezuoke SN, Ezeonwu BU, Adiele KD, Ukoha OM.
    Niger J Clin Pract; 2014; 17(2):196-200. PubMed ID: 24553031
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of autonomic dysfunction among pre-dialysis chronic kidney disease patients in a tertiary hospital, South East Nigeria.
    Onodugo O, Arodiwe E, Okoye J, Ezeala B, Onodugo N, Ulasi I, Ijoma C.
    Afr Health Sci; 2018 Dec; 18(4):950-957. PubMed ID: 30766559
    [Abstract] [Full Text] [Related]

  • 7. High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.
    Busari AA, Oreagba IA, Oshikoya KA, Kayode MO, Olayemi SO.
    Niger Med J; 2019 Dec; 60(6):317-325. PubMed ID: 32180663
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients.
    Al-Ramahi R, Raddad AR, Rashed AO, Bsharat A, Abu-Ghazaleh D, Yasin E, Shehab O.
    BMC Nephrol; 2016 Jul 26; 17():96. PubMed ID: 27456700
    [Abstract] [Full Text] [Related]

  • 9. How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?
    Richarz U, Jacobs A, Spina E.
    Pharmacoepidemiol Drug Saf; 2012 May 26; 21(5):453-62. PubMed ID: 22081534
    [Abstract] [Full Text] [Related]

  • 10. Potential Drug - Drug Interactions among Medications Prescribed to Hypertensive Patients.
    Kothari N, Ganguly B.
    J Clin Diagn Res; 2014 Nov 26; 8(11):HC01-4. PubMed ID: 25584241
    [Abstract] [Full Text] [Related]

  • 11. Use of an on-demand drug-drug interaction checker by prescribers and consultants: a retrospective analysis in a Swiss teaching hospital.
    Beeler PE, Eschmann E, Rosen C, Blaser J.
    Drug Saf; 2013 Jun 26; 36(6):427-34. PubMed ID: 23516005
    [Abstract] [Full Text] [Related]

  • 12. Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital.
    Khaled A, Almaghaslah D, Nagib R, Makki S, Siddiqua A.
    Eur Rev Med Pharmacol Sci; 2023 Jan 26; 27(2):737-743. PubMed ID: 36734729
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
    Khan Q, Ismail M, Haider I, Khan F.
    Int J Clin Pharm; 2017 Dec 26; 39(6):1256-1264. PubMed ID: 28895028
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB, Reis AM, Figueras A, Secoli SR.
    Int J Clin Pharm; 2011 Dec 26; 33(6):1002-9. PubMed ID: 21993569
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK, Mahato SK, Agnihotri A, Pasricha RK, Nath UK, Das B.
    Cancer Treat Res Commun; 2021 Dec 26; 26():100277. PubMed ID: 33348276
    [Abstract] [Full Text] [Related]

  • 16. Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
    Gago-Sánchez AI, Font P, Cárdenas M, Aumente MD, Del Prado JR, Calleja MÁ.
    Pharmacol Res Perspect; 2021 Dec 26; 9(6):e00892. PubMed ID: 34755493
    [Abstract] [Full Text] [Related]

  • 17. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H, Moutaouakkil Y, Sefrioui MR, Moukafih B, Bousliman Y, Bennana A, Lamsaouri J, Makram S, Cherrah Y.
    Pan Afr Med J; 2018 Dec 26; 29():225. PubMed ID: 30100979
    [Abstract] [Full Text] [Related]

  • 18. The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria.
    Ulasi II, Ijoma CK.
    J Trop Med; 2010 Dec 26; 2010():501957. PubMed ID: 20613945
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials.
    Rashdan S, Yang H, Le T, Selby C, Gerber DE, Alvarez CA.
    Clin Drug Investig; 2021 Feb 26; 41(2):161-167. PubMed ID: 33417195
    [Abstract] [Full Text] [Related]

  • 20. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL, Varma DM, Immadisetti K, Rajesh R, Vidyasagar S, Guddattu V.
    Int J Risk Saf Med; 2017 Feb 26; 29(1-2):25-55. PubMed ID: 28885219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.